Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Resolution . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel isovaleraldehyde route enhances purity and yield. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN101622239A reveals a high-yield resolution method for homocysteine-gamma-thiolactone using chiral acids and aromatic aldehydes, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102010400A details a novel chiral resolution route for Rotigotine intermediates, offering high purity and streamlined manufacturing for reliable pharmaceutical supply chains.
Patent CN102887885A details a high-purity Esomeprazole Sodium synthesis via inclusion complex resolution, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114163411A details a scalable crystallization resolution method for dihydromyricetin offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Advanced Friedel-Crafts route for dexmedetomidine HCl offers superior yield and purity. A cost-effective solution for pharmaceutical intermediates manufacturing and supply chain stability.
Optimized synthesis route for Tenofovir Alafenamide reduces costs and improves chirality. Reliable supply chain partner for high-purity pharmaceutical intermediates manufacturing.
Patent CN1742002A discloses novel piperazine intermediates for Levocetirizine. Discover high-purity synthesis routes offering significant cost reduction and supply reliability.
Patent CN100427460C details a scalable L-norvaline synthesis from n-valeric acid, offering cost reduction in API manufacturing and high-purity chiral intermediates.
Patent CN104193635A offers high-purity pregabalin synthesis via Hofmann degradation ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN101973904B reveals organic acid salification for Lisinopril intermediate. Ensures high optical purity and scalable production for global supply chains.
Patent CN110845305B details a high-yield route to L-menthol using organoaluminum catalysts and chiral resolution, offering cost-effective supply chain solutions.
Patent CN106749177A details a novel tartaric acid purification method for SYR-322, ensuring high purity and cost reduction in API manufacturing for global supply chains.
Patent CN101883486B reveals non-chromatographic resolution. Enables cost reduction in pharmaceutical intermediate manufacturing via crystallization.
Patent CN113201516B reveals a solvent-free enzymatic route for L-menthol with >95% ee. Discover cost-effective manufacturing solutions for high-purity terpene alcohols.
Patent CN107011228B details a novel chiral resolution process for Clemastine Fumarate ensuring high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN118026867B details a high-efficiency chiral resolution for Mirogabalin intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN101654445B reveals a cost-effective route for Ramelteon intermediates using mild conditions. This ensures supply chain stability and high purity for global pharmaceutical manufacturers seeking reliable partners.
Patent CN102757356B details a cost-effective splitting process for D-HPG. Enhances supply chain reliability and reduces waste in API intermediate manufacturing significantly.
Patent CN107759623A reveals high-yield Ruxolitinib intermediate route. Eliminates column chromatography for cost reduction and supply chain reliability in API manufacturing.